Event – Building MRI Commercialisation Capability – Supporting Start-ups – 24 Sep 2020

Event – Building MRI Commercialisation Capability – Supporting Start-ups – 24 Sep 2020

Date: 24 September 2020

Time: 2-3pm AEST

Register: Register for free through our eventbrite site


In this webinar we will hear the experiences of three medical research institutes that have achieved recent success with their research commercialisation endeavours.

The webinar will be followed by a panel discussion session with audience Q&A covering efforts to develop state/federal commercialisation capabilities, policy and regulation, funding, and sector promotion.

The session aims to start a discussion about:

  • encouraging a culture of research commercialisation
  • key elements for success in MRI commercial ventures
  • how to give start-ups the best chance of succeeding
  • managing relationships between MRIs and start-ups
  • barriers to achieving success in commercialising MRI research
  • the research commercialisation landscape in Australian jurisdictions
  • broader structural changes that could increase MRI research commercialisation

We want to hear from you about what AAMRI and MRIs can do to help enhance research commercialisation capability in the sector?


Adjunct Professor Paul Watt – Director, Research Services and Innovation, Telethon Kids Institute (WA)

Paul leads the grants and commercialisation office at Telethon Kids Institute. Paul began his career in research completing his PhD in Molecular Biology at Oxford University. For the last 20 years he has focused on technology translation, holding various key roles in public and private biotechnology companies over the last 18 years, including CSO, CEO and non-executive director. He currently serves as non-executive director for several Biotech and Medtech companies.


Dr Cath Latham, Policy and Projects Manager, AAMRI

HOW MUCH COMMERCIALISATION IS HAPPENING IN THE MRI SECTOR? – With less than 40% of the sector’s $2 billion revenue coming from government sources, commercial income is more important than ever. The COVID-19 pandemic has already disrupted key MRI revenue streams, leading to uncertainty. How much commercialisation is the sector doing now? Can we accelerate our commercial activity to help with the postpandemic recovery? Join Cath on a data-driven journey of AAMRI’s 57 MRI members.

Professor Scott Bell – Chief Executive Officer, The Translational Research Institute (QLD)

TRI & START-UPS: THE JOURNEY SO FAR – TRI commenced operations in 2013 and included 650m2 start-up space with access to research expertise, core facilities and clinical trial capabilities. This space is occupied by six start-up companies and is oversubscribed with a waiting list. Scott will explore the operating model, support structure and type of start-ups, along with the growing need for facilities to scale-up.

Dr Parisa Glass – Director of Innovation and Enterprise, The George Institute for Global Health (NSW)

ENTREPRENEURSHIP AND INNOVATION IN GLOBAL HEALTH Parisa will discuss the role of research commercialisation and enterprises in addressing the institute’s biggest health challenges globally. She will speak about both The George Institute for Global Health and George Health and take the audience through the Genovate program and current partnerships such as the Health10X initiative, which is providing the opportunity to work with innovators across Australia.

A/Prof Dominic Wall – Executive Director, Business Ventures, Peter MacCallum Cancer Centre & Chief Scientific Officer, Cell Therapies Pty Ltd

COMMERCIALISATION FOR FUTURE RETURNS BEYOND LICENSING – Healthcare-based research in Australia is typically more focussed on IP protection and licensing opportunities rather than explicitly pursuing company start-ups and other commercial vehicles for value creation. Dominic will share Peter Mac’s perspectives on these issues, and common barriers to commercialisation and value creation.

Find out if your Institute is an AAMRI member by checking our members page.

Zoom Details: Will be provided following confirmation of attendance.